DIA 2023: Tamei Elliott Discusses Changes to the Role of Diversity in Clinical Trials

In an interview at the DIA Global Annual Meeting with Nicholas Saraceno, Tamei Elliott,Senior Manager, Scientific Programs, Drug Information Association, discusses changes to the role of diversity in clinical trials in regard to scientific programing.

Related Content:

Drug Information Association (DIA) Annual MeetingConferences

DIA 2023 Recap: Q&A with DIA President and Global Chief Executive, Marwan Fathallah

Importance of DCTs Moving Forward

AI and Safety: Finding the Signals that Matter